Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Ricky Hsu"'
Autor:
Karam Mounzer, Ricky Hsu, Jennifer S. Fusco, Laurence Brunet, Cassidy E. Henegar, Vani Vannappagari, Chris M. Stainsby, Mark S. Shaefer, Leigh Ragone, Gregory P. Fusco
Publikováno v:
AIDS Research and Therapy, Vol 16, Iss 1, Pp 1-9 (2019)
Abstract Background HLA-B*57:01 screening was added to clinical care guidelines in 2008 to reduce the risk of hypersensitivity reaction from abacavir. The uptake of HLA-B*57:01 screening and incidence of hypersensitivity reaction were assessed in a p
Externí odkaz:
https://doaj.org/article/eb6a93f967da4fe48e4500da57276d04
Autor:
Michael Wohlfeiler, Karam Mounzer, Laurence Brunet, Jennifer Fusco, Vani Vannappagari, Lloyd Curtis, Nassrin Payvandi, Michael Aboud, Ricky Hsu, Philip Lackey, Gregory Fusco
Publikováno v:
Therapeutic Advances in Drug Safety, Vol 11 (2020)
Introduction: A comprehensive assessment of liver disorders was conducted among people living with HIV (PLWH) on a new antiretroviral regimen based on common core agents. Methods: Treatment-naïve and experienced PLWH first initiating dolutegravir (D
Externí odkaz:
https://doaj.org/article/5c8a953b882f4526933a71880c12ec3c
Autor:
Jennifer S Fusco, Laurence Brunet, Vani Vannappagari, Melissa Crawford, Ricky Hsu, Jean van Wyk, Gregory Fusco, Karam Mounzer, Janet Lo, Cassidy Henegar
Publikováno v:
AIDS Research and Human Retroviruses. 37:852-861
With obesity on the rise among people living with HIV (PLWH), there is growing concern that weight gain may result as an undesired effect of antiretroviral therapy (ART). This analysis sought to assess the association between ART regimens and changes
Autor:
Ricky Hsu, Laurence Brunet, Jennifer S Fusco, Karam Mounzer, Leigh Ragone, Gregory Fusco, Mark S. Shaefer, Christina M. Wyatt, Allan R Tenorio, Vani Vannappagari
Publikováno v:
AIDS. 35:1201-1208
OBJECTIVES To assess the risk of adverse diagnoses and laboratory abnormalities associated with a 300 or 150 mg daily dose of lamivudine (3TC) initiated by people with HIV (PWH) with an estimated glomerular filtration rate (eGFR) between at least 30
Autor:
Karam Mounzer, Jean van Wyk, Vani Vannappagari, Ricky Hsu, Gregory Fusco, Lloyd Curtis, Jennifer S Fusco, Cassidy Henegar, Janet Lo, Laurence Brunet
Publikováno v:
AIDS. 35:81-90
Objectives To describe the prevalence and incidence of prediabetes and type 2 diabetes mellitus (T2DM) among people living with HIV (PLHIV) and evaluate the association between antiretroviral therapy (ART) initiation with dolutegravir (DTG), elvitegr
Autor:
Ricky Hsu, Jennifer S Fusco, Laurence Brunet, Vani Vannappagari, Mark S. Shaefer, Alex R. Rinehart, Keith M Rawlings, Kevin R. Frost, Karam Mounzer, Gregory Fusco
Publikováno v:
AIDS patient care and STDs. 35(11)
Preventing HIV transmission is a crucial step in ending the HIV epidemic. Safe and effective pre-exposure prophylaxis (PrEP) has been available in the United States since 2012. We set out to determine if persons at greatest risk for HIV acquisition w
Autor:
Andrew P Beyer, Michael Wohlfeiler, Karam Mounzer, Laurence Brunet, Ricky Hsu, Patrick W. G. Mallon, Girish Prajapati, Jennifer S Fusco, Gregory Fusco
Publikováno v:
Journal of the International AIDS Society
Introduction Although weight gain has been reported with the use of integrase strand transfer inhibitors (InSTI), concurrent use of tenofovir alafenamide (TAF) has been implicated in recent studies. This study examined weight changes in people living
Autor:
Lindsay M. Carter, Cassidy Henegar, Charlotte E. Lane, Teodora Perger, Vani Vannappagari, Karam Mounzer, Rimgaile Urbaityte, Mark S. Shaefer, C. Stainsby, James Oyee, Gary E. Pakes, Ricky Hsu
Publikováno v:
Pharmacotherapy
Introduction Human leukocyte antigen (HLA)‐B*5701 screening identifies patients at increased risk for abacavir (ABC) hypersensitivity reaction (HSR). Screening was adopted in GlaxoSmithKline and ViiV Healthcare clinical trials in 2007 and human imm
Autor:
Lloyd Curtis, Ricky Hsu, Anna Fettiplace, Romina Quercia, Alan Winston, Michael Aboud, C. Stainsby, Jennifer S Fusco, Vani Vannappagari, Naomi Givens, Sarah Puccini
Publikováno v:
Journal of Acquired Immune Deficiency Syndromes (1999)
Supplemental Digital Content is Available in the Text.
Introduction: Psychiatric symptoms (PSs) are reported to occur frequently in people living with HIV and may be associated with specific antiretrovirals. We analyzed PSs observed with doluteg
Introduction: Psychiatric symptoms (PSs) are reported to occur frequently in people living with HIV and may be associated with specific antiretrovirals. We analyzed PSs observed with doluteg
Autor:
Cassidy Henegar, Anthony Mills, Ricky Hsu, Philip Lackey, Felix Carpio, Gerald Pierone, Mike Wohlfeiler, Edwin DeJesus, Jennifer S Fusco, Gregory Fusco
Publikováno v:
Clinical Drug Investigation
Background and Objectives The standard of care for HIV treatment is a three-drug regimen consisting of two nucleoside reverse transcriptase inhibitors (NRTIs) and either a non-nucleoside reverse transcriptase inhibitor, a protease inhibitor (PI) or a